Zobrazeno 1 - 6
of 6
pro vyhledávání: '"M R Carriero"'
Autor:
Giorgio B. Boncoraglio, E. Maccagnano, D. Soligo, L. O. Scappatura, E. A. Parati, M. R. Carriero, L. Robbiolo, Antonio Brucato
Publikováno v:
Neurology. 65(2)
Mastocytosis refers to an uncommon and heterogeneous group of clonal hematologic disorders characterized by pathologic accumulation of mast cells (MCs) in various tissues. In 80 to 90% of cases, abnormal MC infiltration is restricted to the skin (cut
Autor:
Giorgio B. Boncoraglio, Elio Agostoni, S. Iurlaro, M. R. Carriero, Giovanni Cossu, Alfonso Ciccone, A. Gatti, M. Melis
Publikováno v:
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 26(5)
Idiopathic cerebral sinus thrombosis (CST) can cause death and serious neurological disability. It is unknown whether smoking, a major risk factor for arterial stroke, is a risk factor also for CST. This work explored the association between smoking
Publikováno v:
Europe PubMed Central
Autor:
M R Carriero, M.N. Castagnoli, G. de Gaetano, Luciana Mussoni, B Lombardi, R Colombo, G. Pintucci
Publikováno v:
XIth International Congress on Thrombosis and Haemostasis.
We have recently shown that In normal subjects aspirin (1,300 mg) and Indobufen (400 mg), a new cyclo-oxygenase Inhibitor structurally unrelated to salycilate, lower the fibrinolytic activity, without modifying t-PA antigen levels, after venous occlu
Publikováno v:
XIth International Congress on Thrombosis and Haemostasis.
Spontaneous fibrinolytic activity of venous specimens Is greater In the arms than in the legs of normal subjects. This difference might be caused by the different hydrostatic pressure In arms and legs. We tested, on standard fibrin plates, the fibrin
Autor:
V, Bertelé, L, Mussoni, G, del Rosso, G, Pintucci, M R, Carriero, M G, Merati, A, Libretti, G, de Gaetano
Publikováno v:
Thrombosis and haemostasis. 60(2)
Plasma fibrinolytic activity and tissue-type plasminogen activator (t-PA) were defective in response to venous stasis in five out of ten patients with peripheral occlusive artery disease. Discontinuous infusions of iloprost, a stable synthetic analog